Clining and characterization of the guinea pig 5-HT(1F) receptor subtype: A comparison of the pharmacological profile to the human species homolog

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 569-576

  Adham, N ^a   Bard, J A ^a   Zgombick, J M ^a   Durkin, M M ^a   Kucharewicz, S ^a   Weinshank, R L ^a   Branchek, T A ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 Hydroxytryptamine; Heterologous expression systems; Migraine

Indexed keywords

1 (1 NAPHTHYL)PIPERAZINE; 5 CARBAMOYLTRYPTAMINE; ALPHA METHYLSEROTONIN; ANTIMIGRAINE AGENT; DIHYDROERGOTAMINE; MESSENGER RNA; METERGOLINE; METHYSERGIDE; METITEPINE; RADIOLIGAND; RECEPTOR SUBTYPE; RIZATRIPTAN; SEROTONIN; SEROTONIN 1F RECEPTOR; SEROTONIN RECEPTOR; SUMATRIPTAN; ZOLMITRIPTAN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IN SITU HYBRIDIZATION; MALE; MIGRAINE; MODEL; MOLECULAR CLONING; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; TRIGEMINUS GANGLION; ANIMAL; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETICS; GENOME; GUINEA PIG; HAPLORHINI; KIDNEY; METABOLISM; MOLECULAR GENETICS; RADIOASSAY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CLONING, MOLECULAR; GENOME; GUINEA PIGS; HAPLORHINI; HUMANS; IN SITU HYBRIDIZATION; KIDNEY; MALE; MICE; MOLECULAR SEQUENCE DATA; RADIOLIGAND ASSAY; RATS; RECEPTORS, SEROTONIN; RNA, MESSENGER; TRIGEMINAL GANGLION;

EID: 0030610869     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00020-8     Document Type: Article

References (29)

1. 1Dβ receptor. Molecular Pharmacology 41: 1-7.
2. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proceedings of the National Academy of Science U.S.A. 90: 408-412.
3. 1F receptors for β-adrenergic antagonists. Neuropharmacology 33: 387-397.
4. 1E-like" serotonin receptor expressed predominantly in hippocampus. Journal of Biological Chemistry 267: 19761-19764.
5. Bouchelet I., Cohen Z., Séuéla P. and Hamel E. (1995) Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. In Migraine: Toward the Third Millenium ed. M. Sandler, pp. 55-63. Malaga, Spain.
6. Bouchelet I., Cohen Z., Case B., Séguéla P. and Hamel E. (1996) Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Molecular Pharmacology 50: 219-223.
7. Bradford M. (1976) A rapid and sensitive method for the quantification of mocrogram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
8. Branchek T. A., Zgombick J. M., Kucharewicz S. A., Gustafson E. L., Durkin M. M., Bard J. A. and Weinshank R. L. (1996) Molecular perspectives of serotonin receptor subtypes in experimental models of migraine. In Towards Migraine 2000, Developments in Neurology, ed. F. C. Rose. Elsevier, Amsterdam.
9. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33: 367-386.
10. 1B receptor messenger RNA in neurons of the rat trigeminal ganglia. European Journal of Pharmacology 227: 357-359.
11. Cady R. K., Wendt J. K., Kirchner J. R., Sargent J. D., Rothrock J. F. and Skaggs H. Jr (1991) Treatment of acute migraine with subcutaneous sumatriptan. Journal of the American Medical Association 265: 2831-2835.
12. 50) of an enzymatic reaction. Biochemical Pharmacology 22: 3099-3108.
13. 1D receptor genes. Trends in Pharmacological Science 13: 153-159.
14. 1D receptor subtypes. Trends in Pharmacological Sciences 17: 103-105.
15. Hoyer D. and Middlemiss D. N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends in Pharmacological Sciences 10: 130-132.
16. 1F receptor subtype: implications to migraine therapy. Society for Neurosciences Abstracts, 528.10.
17. 1E-like rat and human 5-hydroxytryptamine receptor genes. Proceedings of the National Academy of Science U.S.A. 90: 2184-2188.
18. 1B ligand-binding phenotype by THR355 ASN site directed mutagenesis. Biochemical Pharmacology 44: 1917-1920.
19. Miller J. and Germain R. N. (1986) Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. Journal of Experimental Medicine 164: 1478-1489.
20. Moskowitz M. (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacological Sciences 13: 307-311.
21. 1B receptors. Nature 360: 161-163.
22. 1F receptor. Society for Neurosciences Abstracts, 528.12.
23. 1B receptors. Journal of Neurochemistry 60: 380-383.
24. Peroutka S. J. and Howell T. A. (1994) The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 33: 319-324.
25. 1F receptor agonist, in the neurogenic dural inflammation model of migraine pain. Society for Neurosciences Abstracts, 528.11.
26. 1Dα serotonin receptor gene expression in trigeminal ganglia: implications for anti-migraine drug development. Proceedings of the National Academy of Science U.S.A. 91: 3666-3669.
27. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Archives of Pharmacology 352: 263-275.
28. 1Dβ. Proceedings of the National Academy of Science U.S.A. 89: 3630-3634.
29. 2B-adrenergic receptor. Molecular Pharmacology 38: 681-688.